Digital SPR Expansion Nicoya recently launched a Digital SPR platform and is emphasizing premium performance with unprecedented accessibility, presenting a compelling upsell path to customers seeking scalable biosensor solutions and easier adoption.

Automation Partnerships Strategic integrations with Labman Automation and Opentrons indicate a clear appetite for automated workflows and interoperability, creating opportunities to offer combined hardware, software, and consumables for end-to-end automated biomolecular analysis.

AAV Therapeutics Support The introduction of AAVX and AAV9 Capture Kits signals a focus on gene therapy research, suggesting sales potential to biotech labs pursuing AAV-based therapies with compatible sensors, protocols, and integrated workflows.

Acquisition Momentum Recent acquisition of Applied Photophysics expands capabilities and portfolio, enabling cross-sell of complementary biosensor technologies and broader technical support to existing customers.

Expansion & Scale Growth to a larger employee base and international collaboration signals capacity to handle higher demand, enabling targeted outreach to mid‑size biotech and pharma companies seeking efficient, high-throughput characterization tools.